Zulassung von genomeditierten Nutzpflanzen in der Schweiz

Published: 1 January 2021
Regulierungsoptionen unter Berücksichtigung der Zulassungssysteme in der Europäischen Union und den Vereinigten Staaten von Amerika, Zurich 2021

Related publications

SEE ALL

Insights

Insights – 30.10.2025

Amendments to the Swiss Anti-Money Laundering Act

Amendments to the Swiss Anti-Money Laundering Act

Switzerland is strengthening its anti-money laundering framework. The revised Anti-Money Laundering Act ("AMLA") adopted in September 2025 broadens its scope to include “advisors” who will become subject to certain due diligence obligations currently applicable to financial intermediaries. Advisors are notably lawyers and notaries. The reform aims to align Swiss practice with international Financial Action Task Force ("FATF") standards. The entry into force of the revised AMLA is expected around mid-2026.

Insights – 10.10.2025

Introduction of a Federal Register of Beneficial Owners

Introduction of a Federal Register of Beneficial Owners

On 26 September 2025, the Swiss Parliament adopted the Federal Act on the Transparency of Legal Entities and the Identification of Beneficial Owners (the "Legal Entities Transparency Act", "LETA"). The new law establishes a central federal Transparency Register in which Swiss legal entities and certain foreign entities with a Swiss nexus will be required to register information on their ultimate beneficial owners (UBO). LETA will replace the existing rules on UBO identification applicable to Swiss companies and aligns with evolving international standards, in particular those of the EU. Implementing ordinances are currently being prepared for consultation. The entry into force is expected around mid-2026.
SEE ALL
Lenz & Staehelin {PAGENO}/{nbpg}
{PAGENO}/{nbpg}